{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:38:34Z","timestamp":1758040714424,"version":"3.44.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.amjmed.2021.08.017","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T12:04:15Z","timestamp":1644321855000},"page":"e55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New Lyme Disease Guidelines for Erythema Migrans Lesions Miss the Mark"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3855-9603","authenticated-orcid":false,"given":"Elizabeth L.","family":"Maloney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.amjmed.2021.08.017_bib0001","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.amjmed.2021.06.051","article-title":"Guidelines for Lyme disease are updated","volume":"134","author":"Auwaerter","year":"2021","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.amjmed.2021.08.017_bib0002","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/antibiotics10070754","article-title":"Evidence-based, patient-centered treatment of erythema migrans in the United States","volume":"10","author":"Maloney","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.amjmed.2021.08.017_bib0003","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2021.08.017_bib0004","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome","volume":"4","author":"Rebman","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.amjmed.2021.08.017_bib0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cid\/cis402","article-title":"Treatment of erythema migrans with doxycycline for 10 days versus 15 days","volume":"55","author":"Stupica","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2021.08.017_bib0006","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1128\/JCM.01584-10","article-title":"A twist on Lyme: the challenge of diagnosing European Lyme neuroborreliosis","volume":"49","author":"Makhani","year":"2011","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2021.08.017_bib0007","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijmm.2015.08.017","article-title":"Borrelia burgdorferi sensu stricto and Borrelia afzelii: Population structure and differential pathogenicity","volume":"305","author":"Jungnick","year":"2015","journal-title":"Int J Med Microbiol."},{"key":"10.1016\/j.amjmed.2021.08.017_bib0008","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(92)90270-L","article-title":"Treatment of early Lyme disease","volume":"92","author":"Massarotti","year":"1992","journal-title":"Am J Med."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321005799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321005799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:25:24Z","timestamp":1757582724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934321005799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0002934321005799"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.08.017","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Lyme Disease Guidelines for Erythema Migrans Lesions Miss the Mark","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}